Navigation Links
Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder
Date:11/8/2007

lar disorder in the United States and has provided over $200 million in funding since 1989.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present and future clinical trials and results of such trials, plans and objectives for regulatory approval, litigation, intellectual property, product development, manufacturing plans and performance such as the anticipated growth in the monoclonal antibody market and our other target markets and projected growth in product sales, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, risks associated with: the succes
'/>"/>

SOURCE Repligen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
(Date:3/27/2015)... YORK , March 27, 2015  Delcath ... pharmaceutical and medical device company focused on oncology ... and metastatic liver cancers, announces the reporting of ... Company,s Melphalan Hydrochloride for Injection with the Delcath ... a poster presentation at the Society of Surgical ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
(Date:3/27/2015)... Ticket Down is a reputable source of authentic ... Nebraska on Friday, May 8th and Saturday, May 9th. ... added in Omaha as Garth has done in other markets ... World Tour is continuing its run throughout the United States ... Trisha Yearwood will bring their act to Omaha, NE at ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Endure ... Yoga for functional fitness athletes. This new program matches ... specific protocol for post-workout cool down. This program utilizes ... breath control and mental focus. , Karen Lefurgy, ... started practicing yoga long before I started Crossfit® training, ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global MEMS ... SM1120 MEMS based ultra-miniature pressure sensor designed especially for ... only 220um x 75um provides ample space for 1-French ... With industry leading in vivo drift performance of ... operating pressure range from 0 to 1,100 mmHg absolute. ...
(Date:3/27/2015)... March 27, 2015 Operatic contenders and ... greatness on April 17th. The universally acclaimed baritone Sherrill ... 9th annual Opera Idol at The Merion in Evanston. ... which has drawn aspiring opera singers from around the ... some of the finest young talent in the country,” ...
(Date:3/27/2015)... Dallas, Texas (PRWEB) March 27, 2015 ... Global Glutathione Industry is a professional and in-depth ... glutathione market with a focus on ... basic overview of the industry including definitions, classifications, ... analysis is provided for both the international and ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 3
... Cancer ... PETCO and Blue Buffalo are partnering to raise awareness and funds to fight this devastating disease. ... the Morris Animal Foundation to fund research and finding a cure. , ... Wilton, Conn., and San Diego (PRWEB) April 24, 2010 ...
... ... on hospitals caused by shorter working hours for junior doctors. , ... London (PRWeb UK) April 23, 2010 -- HCL ... part of HCL plc, said today that greater use of flexible and locum doctors ...
... 25th Anniversary EAU Congress ended in Barcelona on Tuesday ... interest and commitment shown by all participants, exhibitors and ... most memorable in the EAU,s congress history." ... due to the vulcanic eruption in Iceland which prevented ...
... and doctors have known for a long time that children ... considerably shorter than most other children. But pediatricians needing to ... set of growth charts based on data collected more than ... advances in the medical care of children with Down syndrome. ...
... ASHT to ... ... Society of Hand Therapists (ASHT) is hosting two meetings for the hand therapy community over ... , , ,ASHT will first hold its 33rd Annual Meeting on June 23. The meeting’s ...
... but opponents call decision a ,rubber stamp, , THURSDAY, ... year of study, a specially appointed panel at the ... guidelines for the treatment of Lyme disease are correct ... adopted in 2006, have long advocated for the short-term ...
Cached Medicine News:Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 2Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 3Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 4Health News:HCL Thames Medics says more locum doctors could help address European Working Time Directive shortage 2Health News:Memorable 25th Anniversary EAU Congress in Barcelona ends with awards 2Health News:Nutrition researchers to develop new growth charts for children with Down syndrome 2Health News:Two Hand Therapy Organizations Collaborate on Jam-Packed Educational Weekend 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 3Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 4
The microprocessor-controlled, Norm-O-Temp® total body hyperthermia water system provides effective heat therapy at less than half the cost of a hyper-hypothermia system....
The control unit manage patient temperatures during long complex surgical procedures to help achieve optimal clinical outcomes....
... T5002 has it's temperature set by ... by pressing a button. A green ... and a flashing amber LED indicates ... temperature. A red LED and an ...
The Cocoon Convective Warming Machine is lightweight, compact and easy to use....
Medicine Products: